國立虎尾科技大學 |

Cell-Based Therapy for Degenerative Retinal Disease

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Cell-Based Therapy for Degenerative Retinal Disease / edited by Marco A. Zarbin, Mandeep S. Singh, Ricardo P. Casaroli-Marano.
其他作者:	Zarbin, Marco A.
面頁冊數:	XI, 280 p. 27 illus., 20 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Stem cells. -
電子資源:	https://doi.org/10.1007/978-3-030-05222-5
ISBN:	9783030052225

Cell-Based Therapy for Degenerative Retinal Disease
Cell-Based Therapy for Degenerative Retinal Disease [electronic resource] /edited by Marco A. Zarbin, Mandeep S. Singh, Ricardo P. Casaroli-Marano. - 1st ed. 2019. - XI, 280 p. 27 illus., 20 illus. in color.online resource. - Stem Cell Biology and Regenerative Medicine,2196-8985. - Stem Cell Biology and Regenerative Medicine,.

Advantages of the Eye as a Target Organ for Cell-Based Therapy in the Central Nervous System -- Proof of Principle: Preclinical Data on Retinal Cell Transplantation -- Clinical and Pathological Features of Selected Human Retinal Degenerative Diseases -- Degenerative Retinal Diseases: Cells sources for cell-based therapy -- Manufacturing of Clinical Grade Cellular Products Under Gmp Conditions -- Regulatory Requirements for Cell-Based Therapy for Degenerative Retinal Disease -- Biomaterials and Scaffolds for Cell Replacement Therapy -- Restoration of cone photoreceptor function in retinitis pigmentosa (RP) – retinal cell-based therapy -- Cell Delivery: Surgical Approaches -- Diagnosis and Complementary Examinations -- Cell Therapy for Degenerative Retinal Disease: special focus on cell fusion-mediated regeneration -- Clinical Trials of Retinal Cell Therapy -- Future Directions -- Index.

This book discusses why specific diseases are being targeted for cell-based retinal therapy, what evidence exists that justifies optimism for this approach, and what challenges must be managed in order to bring this technology from the laboratory into routine clinical practice. There are a number of unanswered questions (e.g., surgical approach to cell delivery, management of immune response, optimum cell type to transplant) that very likely are not going to be answered until human trials are undertaken, but there is a certain amount of “de-risking” that can be done with preclinical experimentation. This book is essential reading for scientists, clinicians, and advanced students in stem cell research, cell biology, and ophthalmology. .

ISBN: 9783030052225

Standard No.: 10.1007/978-3-030-05222-5doiSubjects--Topical Terms:

679759
Stem cells.

LC Class. No.: QH588.S83

Dewey Class. No.: 571.6

Cell-Based Therapy for Degenerative Retinal Disease
LDR:03089nam a22003975i 4500 001 1004524
003 DE-He213
005 20200630222829.0
007 cr nn 008mamaa
008 210106s2019 gw | s |||| 0|eng d
020 $a 9783030052225 $9 978-3-030-05222-5
024 7 $a 10.1007/978-3-030-05222-5 $2 doi
035 $a 978-3-030-05222-5
050 4 $a QH588.S83
072 7 $a PSAK $2 bicssc
072 7 $a SCI017000 $2 bisacsh
072 7 $a PSAK $2 thema
082 0 4 $a 571.6 $2 23
245 1 0 $a Cell-Based Therapy for Degenerative Retinal Disease $h [electronic resource] / $c edited by Marco A. Zarbin, Mandeep S. Singh, Ricardo P. Casaroli-Marano.
250 $a 1st ed. 2019.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Humana, $c 2019.
300 $a XI, 280 p. 27 illus., 20 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Stem Cell Biology and Regenerative Medicine, $x 2196-8985
505 0 $a Advantages of the Eye as a Target Organ for Cell-Based Therapy in the Central Nervous System -- Proof of Principle: Preclinical Data on Retinal Cell Transplantation -- Clinical and Pathological Features of Selected Human Retinal Degenerative Diseases -- Degenerative Retinal Diseases: Cells sources for cell-based therapy -- Manufacturing of Clinical Grade Cellular Products Under Gmp Conditions -- Regulatory Requirements for Cell-Based Therapy for Degenerative Retinal Disease -- Biomaterials and Scaffolds for Cell Replacement Therapy -- Restoration of cone photoreceptor function in retinitis pigmentosa (RP) – retinal cell-based therapy -- Cell Delivery: Surgical Approaches -- Diagnosis and Complementary Examinations -- Cell Therapy for Degenerative Retinal Disease: special focus on cell fusion-mediated regeneration -- Clinical Trials of Retinal Cell Therapy -- Future Directions -- Index.
520 $a This book discusses why specific diseases are being targeted for cell-based retinal therapy, what evidence exists that justifies optimism for this approach, and what challenges must be managed in order to bring this technology from the laboratory into routine clinical practice. There are a number of unanswered questions (e.g., surgical approach to cell delivery, management of immune response, optimum cell type to transplant) that very likely are not going to be answered until human trials are undertaken, but there is a certain amount of “de-risking” that can be done with preclinical experimentation. This book is essential reading for scientists, clinicians, and advanced students in stem cell research, cell biology, and ophthalmology. .
650 0 $a Stem cells. $3 679759
650 0 $a Regenerative medicine. $3 782729
650 0 $a Tissue engineering. $3 558489
650 0 $a Ophthalmology. $3 644487
650 1 4 $a Stem Cells. $3 782732
650 2 4 $a Regenerative Medicine/Tissue Engineering. $3 1020916
700 1 $a Zarbin, Marco A. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1056717
700 1 $a Singh, Mandeep S. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1298029
700 1 $a Casaroli-Marano, Ricardo P. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1298030
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030052218
776 0 8 $i Printed edition: $z 9783030052232
830 0 $a Stem Cell Biology and Regenerative Medicine, $x 2196-8985 $3 1256981
856 4 0 $u https://doi.org/10.1007/978-3-030-05222-5
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)